Genetic Evidence for Repurposing of GLP1R (Glucagon‐Like Peptide‐1 Receptor) Agonists to Prevent Heart Failure

Background This study was designed to investigate the genetic evidence for repurposing of GLP1R (glucagon‐like peptide‐1 receptor) agonists to prevent heart failure (HF) and whether the potential benefit exceeds the benefit conferred by more general glycemic control. Methods and Results We applied 2...

詳細記述

書誌詳細

出版年:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
主要な著者:	Iyas Daghlas, Ville Karhunen, Devleena Ray, Verena Zuber, Stephen Burgess, Philip S. Tsao, Julie A. Lynch, Kyung Min Lee, Benjamin F. Voight, Kyong‐Mi Chang, Emma H. Baker, Scott M. Damrauer, Joanna M. M. Howson, Marijana Vujkovic, Dipender Gill
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2021-07-01
主題:	diabetes mellitus ejection fraction GLP1R heart failure Mendelian randomization
オンライン･アクセス:	https://www.ahajournals.org/doi/10.1161/JAHA.120.020331